174 related articles for article (PubMed ID: 23690123)
1. Optimization of utilization of serum protein analysis: role of the electronic medical record in promoting consultation by pathology.
Zia HM; Singh G
Am J Clin Pathol; 2013 Jun; 139(6):793-7. PubMed ID: 23690123
[TBL] [Abstract][Full Text] [Related]
2. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
Smith J; Raines G; Schneider HG
Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
[TBL] [Abstract][Full Text] [Related]
3. Audit of Use and Overuse of Serum Protein Immunofixation Electrophoresis and Serum Free Light Chain Assay in Tertiary Health Care: A Case for Algorithmic Testing to Optimize Laboratory Utilization.
Heaton C; Vyas SG; Singh G
Am J Clin Pathol; 2016 Apr; 145(4):531-7. PubMed ID: 27124940
[TBL] [Abstract][Full Text] [Related]
4. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
Dasari S; Kohlhagen MC; Dispenzieri A; Willrich MAV; Snyder MR; Kourelis TV; Lust JA; Mills JR; Kyle RA; Murray DL
Mayo Clin Proc; 2022 Feb; 97(2):294-307. PubMed ID: 34887112
[TBL] [Abstract][Full Text] [Related]
5. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
Smith JD; Raines G; Schneider HG
Clin Chem Lab Med; 2016 Jun; 54(6):967-71. PubMed ID: 26677889
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
7. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
8. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
9. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice.
Genzen JR; Murray DL; Abel G; Meng QH; Baltaro RJ; Rhoads DD; Delgado JC; Souers RJ; Bashleben C; Keren DF; Ansari MQ
Arch Pathol Lab Med; 2018 Apr; 142(4):507-515. PubMed ID: 29266967
[TBL] [Abstract][Full Text] [Related]
10. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
Hill PG; Forsyth JM; Rai B; Mayne S
Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.
Willrich MA; Ladwig PM; Andreguetto BD; Barnidge DR; Murray DL; Katzmann JA; Snyder MR
Clin Chem Lab Med; 2016 Jun; 54(6):1085-93. PubMed ID: 26812875
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
13. Performance of the Sebia CAPILLARYS 2 for detection and immunotyping of serum monoclonal paraproteins.
Yang Z; Harrison K; Park YA; Chaffin CH; Thigpen B; Easley PL; Smith JA; Robinson CA; Lorenz RG; Hardy RW
Am J Clin Pathol; 2007 Aug; 128(2):293-9. PubMed ID: 17638665
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
Wolff F; Debaugnies F; Rozen L; Willems D; Brohet F; Brauner J; Stordeur P
Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
[TBL] [Abstract][Full Text] [Related]
16. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
17. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?
Abadie JM; van Hoeven KH; Wells JM
Am J Clin Pathol; 2009 Feb; 131(2):166-71. PubMed ID: 19141376
[TBL] [Abstract][Full Text] [Related]
18. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
19. [Detection of free light chains--a new method of diagnostics of haematological diseases].
Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
[TBL] [Abstract][Full Text] [Related]
20. An audit of immunofixation requesting practices at a South African referral laboratory.
Gounden V; Rampursat Y
Afr J Lab Med; 2014; 3(1):91. PubMed ID: 29043173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
